Furthermore, AKK can promote the recruitment and infiltration of CD4+ T cells into the TME, enhance immune surveillance functions, and inhibit tumor cell immune escape mechanisms, ultimately improving the clinical efficacy of PD‐1 blockade immunotherapy [116]. The gene discussed is PDCD1; the disease is neoplasm.